Catalyst Pharmaceuticals, Inc.
Board Member
2004-01-01–present
Charles B. O’Keeffe
Board Member
Catalyst Pharmaceuticals, Inc.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Charles B. O’Keeffe
Charles B. O’Keeffe is recorded as Board Member at Catalyst Pharmaceuticals, Inc.. Catalyst Pharmaceuticals, Inc. reported in an 8-K filed May 21, 2024 that Charles B. O’Keeffe was appointed Director, effective May 21, 2024. Catalyst Pharmaceuticals, Inc. reported in an 8-K filed August 25, 2023 that Charles B. O’Keeffe was appointed Board of Directors, effective August 22, 2023. Catalyst Pharmaceuticals, Inc. reported in an 8-K filed September 19, 2022 that Charles B. O’Keeffe was appointed Director, effective September 19, 2022.
“Richard J. Daly, Patrick J. McEnany, Donald A. Denkhaus, Molly Harper, Charles B. O’Keeffe, Tamar Thompson, and David S. Tierney were elected to the Company’s Board of Directors ("Board") to serve until the 2025 Annual Meeting of Stockholders or until their successor is duly elected and qualified, or until their earlier death, resignation or removal.”
“Patrick J. McEnany, Richard J. Daly, Donald A. Denkhaus, Molly Harper, Charles B. O’Keeffe, Tamar Thompson, and David S. Tierney were elected to the Company’s Board of Directors (“Board”) to serve until the 2024 Annual Meeting of Stockholders or until their successor is duly elected and qualified, or until their earlier death, resignation or removal.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Catalyst Pharmaceuticals, Inc.
Board Member
Proxy statement
Current2024-05-21–present
-
Catalyst Pharmaceuticals, Inc.
Board Member
Proxy statement
2004-01-01–2025-05-20
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.